BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10974389)

  • 1. The effect of a water/organic solvent interface on the structural stability of lysozyme.
    van de Weert M; Hoechstetter J; Hennink WE; Crommelin DJ
    J Control Release; 2000 Sep; 68(3):351-9. PubMed ID: 10974389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C; Griebenow K
    Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL; Jones AJ
    Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method.
    Pérez C; De Jesús P; Griebenow K
    Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
    Taluja A; Bae YH
    Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of lysozyme by sonication under conditions relevant to microencapsulation.
    Krishnamurthy R; Lumpkin JA; Sridhar R
    Int J Pharm; 2000 Sep; 205(1-2):23-34. PubMed ID: 11000539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres.
    Fu K; Griebenow K; Hsieh L; Klibanov AM; LangerR
    J Control Release; 1999 Apr; 58(3):357-66. PubMed ID: 10099160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres.
    Pérez-Rodriguez C; Montano N; Gonzalez K; Griebenow K
    J Control Release; 2003 Apr; 89(1):71-85. PubMed ID: 12695064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation.
    Sah H
    J Control Release; 1999 Mar; 58(2):143-51. PubMed ID: 10053187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.
    Nam YS; Park TG
    J Microencapsul; 1999; 16(5):625-37. PubMed ID: 10499842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved activity and stability of lysozyme at the water/CH2Cl2 interface: enzyme unfolding and aggregation and its prevention by polyols.
    Pérez C; Griebenow K
    J Pharm Pharmacol; 2001 Sep; 53(9):1217-26. PubMed ID: 11578104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.
    Taluja A; Bae YH
    Mol Pharm; 2007; 4(4):561-70. PubMed ID: 17439239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
    Cho M; Sah H
    J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein.
    Carrasquillo KG; Stanley AM; Aponte-Carro JC; De Jésus P; Costantino HR; Bosques CJ; Griebenow K
    J Control Release; 2001 Oct; 76(3):199-208. PubMed ID: 11578736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres.
    Sah H
    PDA J Pharm Sci Technol; 1999; 53(1):3-10. PubMed ID: 10343502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis.
    Kang F; Singh J
    Int J Pharm; 2003 Jul; 260(1):149-56. PubMed ID: 12818819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques.
    van de Weert M; van 't Hof1 R; van der Weerd J; Heeren RM; Posthuma G; Hennink WE; Crommelin DJ
    J Control Release; 2000 Jul; 68(1):31-40. PubMed ID: 10884577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
    Srinivasan C; Katare YK; Muthukumaran T; Panda AK
    J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.